Evidence map›Paper›PMID 33811184›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2021

SARS-CoV-2 induces double-stranded RNA-mediated innate immune responses in respiratory epithelial-derived cells and cardiomyocytes.

Yize Li, David M Renner, Courtney E Comar, Jillian N Whelan, Hanako M Reyes, Fabian Leonardo Cardenas-Diaz, Rachel Truitt, Li Hui Tan, Beihua Dong, Konstantinos Dionysios Alysandratos and 10 more

Erratum issuedOpen access · hybridAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 180 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
180citing papers in PubMed, 1 pooled it
13.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

180 citing papers in PubMed, 1 synthesis or guideline pooled it, 245 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. SARS-CoV-2 and MERS-CoV disrupt host protein synthesis via nsp1 with differential effects on the integrated stress response.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

120 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

20 authors at 5 institutions in 1 country.

Yize LiDepartment of Microbiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104; weisssr@pennmedicine.upenn.edu yizelee@gmail.com.ORCID https://orcid.org/0000-0003-1721-741X
David M RennerDepartment of Microbiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104.ORCID https://orcid.org/0000-0003-0548-3876
Courtney E ComarDepartment of Microbiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104.ORCID https://orcid.org/0000-0003-0110-7128
Jillian N WhelanDepartment of Microbiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104.ORCID https://orcid.org/0000-0002-2735-2124
Hanako M ReyesDepartment of Microbiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104.
Fabian Leonardo Cardenas-DiazDepartment of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104.ORCID https://orcid.org/0000-0002-6504-478X
Rachel TruittDepartment of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104.
Li Hui TanDepartment of Otorhinolaryngology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104.
Beihua DongDepartment of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195.
Konstantinos Dionysios AlysandratosDepartment of Medicine, The Pulmonary Center, Center for Regenerative Medicine, Boston University School of Medicine, Boston, MA 02118.
Jessie HuangDepartment of Medicine, The Pulmonary Center, Center for Regenerative Medicine, Boston University School of Medicine, Boston, MA 02118.ORCID https://orcid.org/0000-0002-5297-3563
James N PalmerDepartment of Otorhinolaryngology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104.
Nithin D AdappaDepartment of Otorhinolaryngology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104.
Michael A KohanskiDepartment of Otorhinolaryngology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104.ORCID https://orcid.org/0000-0001-8399-364X
Darrell N KottonDepartment of Medicine, The Pulmonary Center, Center for Regenerative Medicine, Boston University School of Medicine, Boston, MA 02118.
Robert H SilvermanDepartment of Cancer Biology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195.ORCID https://orcid.org/0000-0003-2432-992X
Wenli YangDepartment of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104.
Edward E MorriseyDepartment of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104.
Noam A CohenDepartment of Otorhinolaryngology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104.
Susan R WeissDepartment of Microbiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104; weisssr@pennmedicine.upenn.edu yizelee@gmail.com.ORCID https://orcid.org/0000-0002-8155-4528
University of Pennsylvania · USBoston University · USCleveland Clinic Lerner College of Medicine · USCalifornia Institute for Regenerative Medicine · USMonell Chemical Senses Center · US

Funding

Editing Alveolar Progenitor Cells for Correction of Monogenic DiseaseU01HL134745 · NHLBI · CINCINNATI CHILDRENS HOSP MED CTR · PI KOTTON, DARRELL N., MORRISEY, EDWARD E · 2016 to 2022
$8.3M
Control of Viral Pathogenesis by Regulation of 2-5A LevelsR01AI104887 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI SILVERMAN, ROBERT H., WEISS, SUSAN R · 2013 to 2023
$7.6M
Derivation of Transplantable Lung Epithelial Progenitors from iPS CellsR01HL095993 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI Darrell N. Kotton · 2009 to 2026
$7.5M
Wnt signaling in the alveolar nicheR01HL087825 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI MORRISEY, EDWARD E · 2008 to 2021
$6.4M
MERS coronavirus: antagonism of double-stranded RNA induced host response by accessory proteinsR01AI140442 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI Susan R Weiss · 2018 to 2026
$5.1M
Molecular pathways controlling alveolar epithelial remodeling in development and regenerationR01HL132999 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI MORRISEY, EDWARD E · 2016 to 2023
$4.6M
Training in Emerging Infectious DiseasesT32AI055400 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI CHERRY, SARA, HENSLEY, SCOTT ERIC · 2003 to 2022
$4.4M
Multi-modal characterization of three human lung niches at the single cell levelU01HL148857 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI MORRISEY, EDWARD E · 2019 to 2023
$4.4M
A National iPS Cell Network with Deep Phenotyping for Translational ResearchU01TR001810 · NCATS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI GILAD, YOAV, KOTTON, DARRELL N. · 2016 to 2020
$4.4M
TRAINING IN NEUROVIROLOGY AND NEUROIMMUNOLOGYT32NS007180 · NINDS · UNIVERSITY OF PENNSYLVANIA · PI WEISS, SUSAN R · 1985 to 2018
$2.8M
NATIONAL BIOREPOSITORY OF LUNG DISEASE-SPECIFIC HUMAN INDUCED PLURIPOTENT STEM CELLS:THE PURPOSE OF THIS RESOURCE IS TO BUILD AND SUPPORT A CRITICAL75N92020C00005 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI N/A, N/A · 2021 to 2024
$2.6M
CSRD VA I01 CX001617NCATS NIH HHS U01 TR001810NHLBI NIH HHS 75N92020C00005NHLBI NIH HHS R01 HL087825NHLBI NIH HHS R01 HL095993NHLBI NIH HHS R01 HL132999NHLBI NIH HHS U01 HL134745NHLBI NIH HHS U01 HL148857NIAID NIH HHS R01 AI104887NIAID NIH HHS R01 AI140442NIAID NIH HHS T32 AI055400NIH HHS N0175N92020C00005NINDS NIH HHS T32 NS007180
6 · The paper itself

Abstract

Coronaviruses are adept at evading host antiviral pathways induced by viral double-stranded RNA, including interferon (IFN) signaling, oligoadenylate synthetase-ribonuclease L (OAS-RNase L), and protein kinase R (PKR). While dysregulated or inadequate IFN responses have been associated with severe coronavirus infection, the extent to which the recently emerged SARS-CoV-2 activates or antagonizes these pathways is relatively unknown. We found that SARS-CoV-2 infects patient-derived nasal epithelial cells, present at the initial site of infection; induced pluripotent stem cell-derived alveolar type 2 cells (iAT2), the major cell type infected in the lung; and cardiomyocytes (iCM), consistent with cardiovascular consequences of COVID-19 disease. Robust activation of IFN or OAS-RNase L is not observed in these cell types, whereas PKR activation is evident in iAT2 and iCM. In SARS-CoV-2-infected Calu-3 and A549

Indexed as

Immunity, InnateA549 CellseIF-2 KinaseEndoribonucleasesEpithelial CellsHumansLungMiddle East Respiratory Syndrome CoronavirusMyocytes, CardiacNoseRNA, Double-StrandedSARS-CoV-2Virus Replication2-5A-dependent ribonucleaseeIF-2 KinaseEndoribonucleasesRNA, Double-Strandedinterferoninterferon signaling genesOAS-RNase LPKRSARS-CoV-2

Identifiers

PMID33811184
PMCPMC8072330
OpenAlexW3139784018

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.